Heather D. Turner, VP, General Counsel & Secretary at Orexigen Therapeutics, Inc. (OREX), sold 300,000 shares at $4.47 ($1.3M) on 2014-09-22, disclosed to the SEC on 2014-09-22.
Open-market sale of $1.3M OREX by VP, General Counsel & Secretary. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| OREX | SELL | 2014-12-04 | $136K | — | Filing → |
| OREX | SELL | 2014-11-26 | $183K | — | Filing → |
| OREX | SELL | 2012-07-19 | $633K | — | Filing → |